TD Cowen reiterated its Buy rating and $105.00 price target on Novo Nordisk (NYSE: NVO) Wednesday following meetings with the company’s senior leadership in Copenhagen. The pharmaceutical giant, with ...

CMG's sales weakness is due to industry challenges, but with a plan to boost traffic and loyalty program, analyst maintains a ...

The tech exec is now wealthier than Mark Zuckerberg and Jeff Bezos, with a $250 billion fortune—but he’ll have a hard time ...

Lear stock gets a bullish $115 price target from Bank of America after strong Q1 earnings and analyst upgrades fuel investor ...

Chipotle’s first quarter saw positive market reception despite revenue missing Wall Street expectations, as management ...

CNBC reported that Philippe Laffont, founder of Coatue Management, said that the volatility of Bitcoin initially stopped him, ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: ...

Nvidia shareholders have been on a rollercoaster this year. The stock peaked at $153.13 early in 2025, before dropping to a 52-week low of $86.62 in April. The announced pause in U.S.-China tariffs ...

Credit card issuers are trying to attract more higher-end customers with the promise of more rewards. But there’s a catch: ...

Asked last month whether his western railroad might merge with an eastern network to haul freight straight across the U.S., ...

Oppenheimer isn’t budging on its $140 price target for Abbott Labs, clearly still smitten with the company's Volt system and ...

Starbucks isn't sipping from the profitability cup just yet, but UBS thinks the brew might improve—eventually. UBS maintained ...